000 01375 a2200373 4500
005 20250514072704.0
264 0 _c20030805
008 200308s 0 0 eng d
022 _a0007-0920
024 7 _a10.1038/sj.bjc.6601048
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aJin, W
245 0 0 _aRoles of the PI-3K and MEK pathways in Ras-mediated chemoresistance in breast cancer cells.
_h[electronic resource]
260 _bBritish journal of cancer
_cJul 2003
300 _a185-91 p.
_bdigital
500 _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, Non-P.H.S.; Research Support, U.S. Gov't, P.H.S.
650 0 4 _aAntineoplastic Agents
_xpharmacology
650 0 4 _aApoptosis
650 0 4 _aBreast Neoplasms
_xpathology
650 0 4 _aDrug Resistance, Neoplasm
_xphysiology
650 0 4 _aFemale
650 0 4 _aHumans
650 0 4 _aMAP Kinase Kinase Kinase 1
650 0 4 _aPhosphatidylinositol 3-Kinases
_xpharmacology
650 0 4 _aProtein Serine-Threonine Kinases
_xpharmacology
650 0 4 _aTumor Cells, Cultured
700 1 _aWu, L
700 1 _aLiang, K
700 1 _aLiu, B
700 1 _aLu, Y
700 1 _aFan, Z
773 0 _tBritish journal of cancer
_gvol. 89
_gno. 1
_gp. 185-91
856 4 0 _uhttps://doi.org/10.1038/sj.bjc.6601048
_zAvailable from publisher's website
999 _c12620691
_d12620691